The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis

被引：0
|
作者：
Fa Mee Doh
Tae-Ik Chang
Hyang Mo Koo
Mi Jung Lee
Dong Ho Shin
Chan Ho Kim
Kwang Il Ko
Hyung Jung Oh
Tae-Hyun Yoo
Shin-Wook Kang
Dae-Suk Han
Seung Hyeok Han
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] NHIC Ilsan Hospital,Division of Nephrology
[3] Yonsei University,Brain Korea 21 for Medical Science, Severance Biomedical Science Institute
来源：
Cardiovascular Drugs and Therapy | 2012年 / 26卷
关键词：
HMG-CoA reductase inhibitor; Insulin resistance; Peritoneal dialysis; Adipokine; Chronic inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 509
页数：8
相关论文
共 50 条
  • [1] The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis
    Doh, Fa Mee
    Chang, Tae-Ik
    Koo, Hyang Mo
    Lee, Mi Jung
    Shin, Dong Ho
    Kim, Chan Ho
    Ko, Kwang Il
    Oh, Hyung Jung
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Han, Dae-Suk
    Han, Seung Hyeok
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (06) : 501 - 509
  • [2] Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis
    Han, Seung Hyeok
    Kang, Ea Wha
    Yoon, Se-Jung
    Yoon, Hyang Sook
    Lee, Hyun Chul
    Yoo, Tae Hyun
    Choi, Kyu Hun
    Han, Dae-Suk
    Kang, Shin-Wook
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (11) : 3722 - 3728
  • [3] Pitavastatin: A New HMG-CoA Reductase Inhibitor
    Wensel, Terri M.
    Waldrop, Bruce A.
    Wensel, Brian
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 507 - 514
  • [4] Mechanism of preventive effect of HMG-CoA reductase inhibitor on diabetic nephropathy
    Yokota, T
    Utsunomiya, K
    Murakawa, Y
    Kurata, H
    Tajima, N
    KIDNEY INTERNATIONAL, 1999, 56 : S178 - S181
  • [5] Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin
    Muck, W
    Ritter, W
    Ochmann, K
    Unger, S
    Ahr, G
    Wingender, W
    Kuhlmann, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1997, 35 (06) : 255 - 260
  • [6] NK-104: a novel synthetic HMG-CoA reductase inhibitor
    Kajinami, K
    Mabuchi, H
    Saito, Y
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (11) : 2653 - 2661
  • [7] Dyslipidemias and HMG-CoA reductase inhibitor prescription in heart transplant recipients
    de Denus, S
    Al-Jazairi, A
    Loh, E
    Jessup, M
    Stanek, EJ
    Spinler, SA
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (7-8) : 1136 - 1141
  • [8] Synthesis and characterization of Rosuvastatin calcium impurity A; a HMG-CoA reductase inhibitor
    Lee, Young Hee
    Viji, Mayavan
    Lee, Eunhwa
    Jo, Hyeju
    Yoo, Kyung
    Sim, Jaeuk
    Lee, Sunhwan
    Lee, Kiho
    Lee, Heesoon
    Jung, Jae-Kyung
    TETRAHEDRON LETTERS, 2017, 58 (26) : 2614 - 2617
  • [9] HMG CoA reductase inhibitors (statins) for dialysis patients
    Palmer, Suetonia C.
    Navaneethan, Sankar D.
    Craig, Jonathan C.
    Johnson, David W.
    Perkovic, Vlado
    Nigwekar, Sagar U.
    Hegbrant, Jorgen
    Strippoli, Giovanni F. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (09):
  • [10] Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs
    Suzuki, H
    Aoki, T
    Tamaki, T
    Sato, F
    Kitahara, M
    Saito, Y
    ATHEROSCLEROSIS, 1999, 146 (02) : 259 - 270
12345